New sleep program aims to help Alzheimer's patients and caregivers rest better

NCT ID NCT05452031

First seen Jun 21, 2026 · Last updated Jun 21, 2026

Summary

This study tests a behavioral sleep program called Care2Sleep for people with Alzheimer's disease and their caregivers. The program includes sleep hygiene, activity, and light exposure. Researchers will compare it to a sleep education group to see if it improves sleep, health, and quality of life. The trial involves 672 participants and will be delivered in person or via telehealth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLEEP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California Los Angeles

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact

    Contact

  • University of California San Diego

    RECRUITING

    La Jolla, California, 92093, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Veterans Affairs Greater Los Angeles Healthcare System

    RECRUITING

    Los Angeles, California, 91343, United States

    Contact Phone: •••-•••-••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Care2Sleep behavioral sleep program

What this could lead to

If it works, this could provide a practical, non-drug way to improve sleep and well-being for both Alzheimer's patients and their caregivers.

What could go wrong

This is a behavioral intervention study, not a drug trial, so benefits may be modest. Results depend on adherence and may not apply to all patients or settings.

Conditions

The condition(s) this trial relates to.

Dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.